|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.49 SEK | -2.92% |
|
-5.93% | +12.94% |
| 05-21 | OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
OncoZenge AB (publ) reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was SEK 3.89 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.94% | 3.81M | |
| +38.69% | 728B | |
| +34.28% | 603B | |
| -4.49% | 360B | |
| +20.24% | 332B | |
| +2.12% | 279B | |
| +17.02% | 244B | |
| +9.31% | 207B | |
| -5.07% | 205B | |
| -0.35% | 163B |
ONCOZENGE AB 
